ELVN a speculative biotech with a leukemia drug seemingly favored by Adam Feuerstein...

ELVN might be worth looking into and doing a full and complete due diligence for any high-risk biotech investors to see if he's right or wrong.

Loading Twitter/X Embed...
If tweet fails to load, click here.

The Company does look interesting. Below is some info from the Company's latest ER.

Twitter Link